Beyond Air, Inc.
XAIR · Healthcare · $2M
After-hours $2.830.00%
Price
$9.33
$2.83
Jul 1, 26Sep 29, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$2M+14.6%
6/'26 vs prev quarter
Company Health
Market Cap$2M
Operating Margin-364.8%
Cash on Hand$10M481.2% of market cap
Free Cash Flow$-20M-961.2% of market cap
Among 114 Medical - Devices peers
LowMedianHigh
PSR0.3xmedian 2.3xPBR1.0xmedian 2.6xROE-1677.2%median -26.3%Beyond Air to Participate in the 2026 Cantor Global Healthcare ConferenceSep 2
Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)Aug 31
Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone PaymentsAug 25
Beyond Air, Inc. (XAIR) Q1 2027 Earnings Call TranscriptAug 13
Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate UpdateAug 13
Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026Aug 4
